|
Volumn 70, Issue 1-2, 2001, Pages 183-191
|
Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)
|
Author keywords
Biphosphonate; Diclofenac; Osteotropic drug delivery system; Prodrug; Rat adjuvant
|
Indexed keywords
ADJUVANT;
DICLOFENAC;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHONIC ACID DERIVATIVE;
PRODRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTHRITIS;
ARTICLE;
BONE;
DIGESTIVE SYSTEM INJURY;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG POTENCY;
DRUG SPECIFICITY;
DRUG TISSUE LEVEL;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SUSTAINED DRUG RELEASE;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, EXPERIMENTAL;
BONE AND BONES;
DICLOFENAC;
DIPHOSPHONATES;
DRUG DELIVERY SYSTEMS;
FEMALE;
FEMUR;
INJECTIONS, INTRAVENOUS;
PRODRUGS;
RATS;
RATS, SPRAGUE-DAWLEY;
|
EID: 0035966508
PISSN: 01683659
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-3659(00)00355-2 Document Type: Article |
Times cited : (76)
|
References (22)
|